Mitogen‐activated protein kinase (MAPK) signaling pathways play an important role in controlling embryonic proliferation and differentiation. It has been demonstrated that sequential lipophilic signal transduction mediators that participate in the MAPK pathway are null post‐implantation lethal. It is not clear why the lethality of these null mutants arises after implantation and not before. One hypothesis is that the gene product of these post‐implantation lethal null mutants are not present before implantation in normal embryos and do not have function until after implantation. To test this hypothesis, we selected a set of lipophilic genes mediating MAPK signal transduction pathways whose null mutants result in early peri‐implantation or placental lethality. These included FRS2α, GAB1, GRB2, SOS1, Raf‐B, and Raf1. Products of these selected genes were detected and their locations and functions indicated by indirect immunocytochemistry and Western blotting for proteins and RT‐polymerase chain reaction (PCR) for mRNA transcription. We report here that all six signal mediators are detected at the protein level in preimplantation mouse embryo, placental trophoblasts, and in cultured trophoblast stem cells (TSC). Proteins are all detected in E3.5 embryos at a time when the first known mitogenic intercellular communication has been documented. mRNA transcripts of two post‐implantation null mutant genes are expressed in mouse preimplantation embryos and unfertilized eggs. These mRNA transcripts were detected as maternal mRNA in unfertilized eggs that could delay the lethality of null mutants. All of the proteins were detected in the cytoplasm or in the cell membrane. This study of spatial and temporal expression revealed that all of these six null mutants post‐implantation genes in MAPK pathway are expressed and, where tested, phosphorylated/activated proteins are detected in the blastocyst. Studies on RNA expression using RT‐PCR suggest that maternal RNA could play an important role in delaying the presence of the lethal phenotype of null mutations. Mol. Reprod. Dev. 71: 1–11, 2005. © 2005 Wiley‐Liss, Inc.

To understand how mitogenic signals are transduced into the trophoblasts in preimplantation embryos, the expression of mitogen‐activated protein kinase (MAPK) pathway molecules was tested. We used immunocytochemical means and reverse transcriptase‐polymerase chain reaction to test whether MAPK pathway molecule gene products exist at the protein and phosphoprotein level in the zygote and the RNA level in the egg and zygote. In addition, all antibodies detected the correct‐sized major band in Westerns of placental cell lines representing the most prevalent cell type in preimplantation embryos. A majority of mRNA transcripts of MAPK pathway genes were detected in unfertilized eggs, and all were expressed in the zygote. We found that the MAPK pathway protein set consisting of the following gene products was present: FRS2α, GRB2, GAB1, SOS1, Ha‐ras, Raf1/RafB, MEK1,2,5, MAPK/ERK1,2, MAPK/ERK5, and RSK1,2,3 (see abbreviations). These proteins were detected in trophoblasts in embryonic day (E) 3.5 embryos when they could mediate mitogenic fibroblast growth factor signals from the embryo or colony stimulating factor‐1 signals from the uterus. The phosphorylation state and position of the phosphoproteins in the cells suggested that they might function in mediating mitogenic signals. Interestingly, a subtle transition from maternal MAPK function to zygotic function was suggested by the localization for three MAPK pathway enzymes between E2.5 and E3.5, Raf1 phospho is largely cell membrane‐localized at E2.5 and E3.5, and MEK1,2 phospho accumulates in the nucleus on E2.5 and E3.5. However, MAPK phospho shifts from nuclear accumulation at E2.5 to cytoplasmic accumulation at E3.5. This finding is similar to the cytoplasmic MAPK phospho localization reported in fibroblast growth factor signaling fields in postimplantation embryos (Corson et al. [ 2003 ] Development 130:4527–4537). This spatial and temporal expression study lays a foundation to plan and analyze perturbation studies aimed at understanding the role of the major mitogenic pathway in preimplantation mouse embryos. Developmental Dynamics 231:72–87, 2004. © 2004 Wiley‐Liss, Inc.

It is clear that G1–S phase control is exerted after the mouse embryo implants into the uterus 4.5 days after fertilization (E4.5); null mutants of genes that control cell cycle commitment such as max, rb (retinoblastoma), and dp1 are embryonic lethal after implantation with proliferation phenotypes. But, a number of studies of genes mediating proliferation control in the embryo after fertilization‐implantation have yielded confusing results. In order to understand when embryos might first exert G1–S phase regulatory control, we assayed preimplantation mouse embryos for the acquisition of expression of mRNA, protein, and phospho‐protein for max, Rb, and DP‐1, and for the proliferation‐promoting phospho‐protein forms of mycC (thr58/ser62) and Rb (ser795). The key findings are that: (1) DP‐1 protein was present in the nucleus as early as the four‐cell stage onwards, (2) max protein was in the nucleus, suggesting function from the four‐cell stage onwards, (3) both mycC and Rb all form protein was present at increasing quantities in the cytoplasm from the 2 cell and 4/8 cell stage, respectively, (4) the phosphorylated form of mycC phospho was present in the nucleus at high levels from the two‐cell stage through blastocyst‐stage, and (5) the phosphorylated form of Rb was detected at low levels in the two‐cell stage embryo and was highly expressed at the 4/8‐cell stage through the blastocyst stage. Taken together, these data suggest that activation of mycC phospho/max dimer pairs, (E2F)/DP‐1 dimer pairs, and repression of Rb inhibition of cell cycle progression via phosphorylation at ser795 occurs at the earliest stages of embryonic development. In addition, the presence of max, mycC phospho, DP‐1, and Rb phospho in the nuclei of embryonic and placental lineage cells in the blastocyst and in trophoblast stem cells suggests that a similar type of cell cycle regulation is present throughout preimplantation development and in both embryonic and extra‐embryonic cell lineages.

Serine-threonine kinases and transcription factors play important roles in the G1-S phase progression of the cell cycle. Assays that use quantitative fluorescence by immunocytochemical means, or that measure band strength during Western blot analysis, may have confused interpretations if the intention is to measure G1-S phase commitment of a small subpopulation of phosphorylated proteins, when a larger conversion of the same population of proteins can occur during late G2 and M phases. In mouse trophoblast stem cells (TSC), a human placental cell line (HTR), and/or mouse preimplantation embryos, 8/19 serine-threonine and tyrosine kinases, 3/8 transcription factors, and 8/14 phospho substrate and miscellaneous proteins were phosphorylated at higher levels in M phase than in interphase. Most phosphoproteins appeared to associate with the spindle complex during M phase, but one (p38MAPK) associated with the spindle pole and five (Cdx2, MEK1, 2, p27, and RSK1) associated with the DNA. Phosphorylation was detected throughout apparent metaphase, anaphase and telophase for some proteins, or for only one of these segments for others. The phosphorylation was from 2.1- to 6.2-fold higher during M phase compared with interphase. These data suggest that, when planning and interpreting quantitative data and perturbation experiments, consideration must be given to the role of serine-threonine kinases and transcription factors during decision making in M phase as well as in G1-S phase.

Objective: To test early-gestation human placenta, a human trophoblast cell line, mouse eggs, preimplantation embryos, and a mouse trophoblast cell line for the expression of mRNA transcripts for stress-activated protein kinase/c-Jun N-terminal kinase (SAPKgamma/JNK1, SAPKalpha/JNK2, and SAPKbeta/JNK3).Design: Whole RNA was isolated from the tissue sources listed above and control tissues, and reverse transcription-polymerase chain reaction (RT-PCR) was performed to assay for the qualitative and semiquantitative presence of SAPKgamma/JNK1, SAPKalpha/JNK2, and SAPKbeta/JNK3.Setting: None.Patient(s): None.Intervention(s): None.Main Outcome Measure(s): The presence and magnitude of amplimer amounts in gels or gene hybridization on Affymetrix cDNA arrays of RT-PCR products of reactions for SAPKgamma/JNK1, SAPKa/JNK2, and SAPKbeta/JNK3.Result(s): SAPKgamma/JNK1 and SAPKalpha/JNK2 mRNA transcripts are present in early-gestation human placenta, a human trophoblast cell line, mouse eggs, preimplantation embryos, and a mouse trophoblast cell line at levels similar to positive control levels. SAPKalpha/JNK2 is expressed at the highest level of the three transcripts in the family. SAPKbeta/JNK3 is present at levels that are 1/100-1/1,000 those of the positive control and in some cases at the apparent level of the negative control (previously measured by the less-sensitive Northern blot analysis). Analysis with an Affymetrix cDNA array suggested that SAPKalpha/JNK2 and 38 kDa mitogen-activated protein kinase had the highest mRNA expression measured for each of three family members.Conclusion(s): Mitotic placental trophoblast cell lines and primary conceptus/embryo samples containing early placental trophoblasts express SAPKa/JNK2 at higher levels than SAPKgamma/JNK1, but not (only low background levels of) SAPKbeta/JNK3 mRNA transcripts. This suggests that SAPKgamma/JNK1 and SAPKalpha/ JNK2 may be important mediators of stress-induced responses in early implanting conceptuses that could mediate embryo loss. (C) 2004 by American Society for Reproductive Medicine.

Hepatocyte growth factor (HGF) is implicated in placental development; hgfr and hgf null mutant embryos develop placental insufficiency and lethality at 11.5 days (E11.5) after fertilization. The function of HGF in placentation at implantation (E4.5) has not been studied. Using reverse transcription-polymerase chain reaction, we detected HGF receptor (HGFR) mRNA in preimplantation embryos and in cultured blastocyst outgrowths. HGFR protein was detected in trophoblast cells in blastocyst outgrowths. HGF mRNA was not detected at these stages but was detected in the uterus at E5.5. Using in situ hybridization, we detected HGF mRNA in the mesometrial uterus, near the embryo, from E6.5 through E8.5. At E8.5, HGFR mRNA was detected in the chorionic placenta, and HGF mRNA was detected in the allantois. The expression for HGF and HGFR suggested a maternal-to-embryonic communication before the development of the allantois. To test this, blastocyst outgrowths were cultured with HGF. HGF stimulated the outgrowth of trophoblasts in a time-dependent manner and stimulated the expression of proliferating cell nuclear antigen, but it did not scatter trophoblasts. HGF stimulated an increase in the trophoblast cell number, but caused a decrease in the total number of terminally differentiated trophoblasts expressing placental lactogen-1 protein. These data suggest that HGF stimulates the cell division, but not the differentiation, of trophoblast cells during implantation.

Molecular Reproduction and DevelopmentVolume 52, Issue 2 p. 234-240 MiniReviewFree Access It's not just baby's babble/Babel: Recent progress in understanding the language of early mammalian development: A minireview Daniel A. Rappolee, Corresponding Author Daniel A. Rappolee [email protected] Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, Illinois Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois Lurie Cancer Center, Center for Reproductive Sciences, Northwestern University, Chicago, Illinois Feinberg Cardiovascular Research Institute, Center for Reproductive Sciences, Northwestern University, Chicago, IllinoisDepartment of Obstetrics and Gynecology, Northwestern University Medical School, 303 E. Chicago Avenue, Tarry Building 4-725, Chicago, IL 60611.Search for more papers by this author Daniel A. Rappolee, Corresponding Author Daniel A. Rappolee [email protected] Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, Illinois Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois Lurie Cancer Center, Center for Reproductive Sciences, Northwestern University, Chicago, Illinois Feinberg Cardiovascular Research Institute, Center for Reproductive Sciences, Northwestern University, Chicago, IllinoisDepartment of Obstetrics and Gynecology, Northwestern University Medical School, 303 E. Chicago Avenue, Tarry Building 4-725, Chicago, IL 60611.Search for more papers by this author First published: 04 January 1999 https://doi.org/10.1002/(SICI)1098-2795(199902)52:2<234::AID-MRD15>3.0.CO;2-HCitations: 26AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. 1998. Targeted disruption of FGFR2 suggests a role for FGF signaling in pre-gastrulation mammalian development. Proc Nat Acad Sci USA 95: 5082–5087. Medline 10.1073/pnas.95.9.5082 CASPubMedWeb of Science®Google Scholar Becker S, Wang ZJ, Massey H, Arauz A, Labosky P, Hammerschmidt M, St-Jacques B, Bumcrot, D, McMahon A, Grabel L. 1997. A role for Indian hedgehog in extraembryonic endoderm differentiation in F9 cells and the early mouse embryo. Dev Biol 187: 298–310. Medline 10.1006/dbio.1997.8616 CASPubMedWeb of Science®Google Scholar Beckman DA, Koszala TR, Jensen M, Brent RL. 1990. Experimental manipulation of the rodent visceral yolk sac. Teratology 41: 396–404. 10.1002/tera.1420410405 Web of Science®Google Scholar Behrendtsen O, Alexander CM, Werb Z. 1995. Cooperative interactions between extracellular matrix, integrins and parathyroid hormone–related peptide regulate parietal endoderm differentiation in mouse embryos. Development 121: 4137–4148. Medline CASPubMedWeb of Science®Google Scholar Brison DR, Schultz RM. 1998. Increased incidence of apoptosis in transforming growth factor alpha–deficient mouse blastocysts. Biol Reprod 59: 136–144. Medline 10.1095/biolreprod59.1.136 CASPubMedWeb of Science®Google Scholar Chai N, Patel Y, Jacobson K, McMahon J, McMahon A, Rappolee DA. 1998. FGF is an essential regulator of the fifth cell division in the preimplantation mouse embryo. Dev Biol 198: 105–115. Medline CASPubMedWeb of Science®Google Scholar Chen WS, Manova K, Weinstein DC, Duncan SA, Plump AS, Prezioso VR, Bachvarova RF, Darnell JE Jr. 1994. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 15: 2466–2477. 10.1101/gad.8.20.2466 Web of Science®Google Scholar Copp AJ. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet 11: 87–93. Medline 10.1016/S0168-9525(00)89008-3 CASPubMedWeb of Science®Google Scholar Cross JC, Flannery ML, Blanar MA, Steingrimsson E, Jenkins NA, Copeland NG, Rutter WJ, Werb Z. 1995. Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development. Development 121: 2513–2523. Medline CASPubMedWeb of Science®Google Scholar Dufort D, Schwartz L, Harpal K, Rossant J. 1998. The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development 125: 3015–3025. Medline 10.1242/dev.125.16.3015 CASPubMedWeb of Science®Google Scholar Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267: 246–249. Medline 10.1126/science.7809630 CASPubMedWeb of Science®Google Scholar Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmar A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW. 1996. The tumor suppressor gene BRCA-1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009–1024. Medline 10.1016/S0092-8674(00)81302-1 CASPubMedWeb of Science®Google Scholar Hyatt BA, Yost HJ. 1998. The left-right coordinator: the role of Vg1 in organizing left-right axis formation. Cell 93: 37–46. Medline 10.1016/S0092-8674(00)81144-7 CASPubMedWeb of Science®Google Scholar Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206–208. Medline 10.1038/378206a0 CASPubMedWeb of Science®Google Scholar LaRue L, Ohsugi J, Hirchenhain J, Kemler R. 1994. E-cadherin mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci USA 91: 8263–8267. Medline 10.1073/pnas.91.17.8263 CASPubMedWeb of Science®Google Scholar Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. 1997. Multiple female reproductive failures in cyclooxygenase 2–deficient mice. Cell 91: 197–208. Medline 10.1016/S0092-8674(00)80402-X CASPubMedWeb of Science®Google Scholar Ma L, Benson GV, Lim H, Dey SK, Maas RL. 1998. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 197: 141–154. Medline 10.1006/dbio.1998.8907 CASPubMedWeb of Science®Google Scholar Rappolee DA, Basilico C, Patel Y, Werb Z. 1994. Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development 120: 2259–2269. Medline 10.1242/dev.120.8.2259 CASPubMedWeb of Science®Google Scholar Rappolee DA. 1998. Growth factors and hormones in mammalian development. Growth factors in the mammalian pre- and post-implantation embryo. In: R Dickson, D Salomon, editors. Hormones and growth factors in development and neoplasia. New York: Wiley. p 93–115. Google Scholar Rosenquist TA, Martin GR. 1995. Visceral endoderm-1 (VE-1): an antigen marker that distinguishes anterior from posterior embryonic visceral endoderm in the early post-implantation mouse embryo. Mech Dev 49: 117–121. Medline 10.1016/0925-4773(94)00308-A CASPubMedWeb of Science®Google Scholar Spyropoulos DD, Capecchi M. 1994. Targeted disruption of the even-skipped gene, evx-1, causes early postimplantation lethality of the mouse conceptus. Genes Dev 8: 1949–1961. Medline 10.1101/gad.8.16.1949 CASPubMedWeb of Science®Google Scholar Riley, P, Anson-Cartwright L, Cross JC. 1998. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18: 271–275. Medline 10.1038/ng0398-271 CASPubMedWeb of Science®Google Scholar Taniguchi F, Harada T, Yoshids S, Iwabe T, Onohara Y, Tanikawa M, Terakawa N. 1998. Paracrine effects of bFGF and KGF on the process of mouse blastocyst implantation. Mol Reprod Dev 50: 54–62. Medline 10.1002/(SICI)1098-2795(199805)50:1<54::AID-MRD7>3.0.CO;2-W CASPubMedWeb of Science®Google Scholar Thomas P, Brickman JM, Popperl H, Krumlauf R, Beddington RS. 1997. Axis duplication and anterior identity in the mouse embryo. Cold Spring Harb Symp Quant Biol 62: 115–125. Medline 10.1101/SQB.1997.062.01.016 CASPubMedWeb of Science®Google Scholar Thomas PQ, Brown A, Beddington RS. 1998. Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development 125: 85–94. Medline 10.1242/dev.125.1.85 CASPubMedWeb of Science®Google Scholar Threadgill DW, Dlugosz J, Hansen L, Tennenbaum T, Lichti U, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230–234. Medline 10.1126/science.7618084 CASPubMedWeb of Science®Google Scholar Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M, Matsushiro A, Yoshimura Y, Morita T. 1996. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Nat Acad Sci USA 93: 6236–6240. Medline 10.1073/pnas.93.13.6236 CASPubMedWeb of Science®Google Scholar Varlet I, Collignon J, Robertson EJ. 1997. Nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development 124: 1033–1044. Medline 10.1242/dev.124.5.1033 CASPubMedWeb of Science®Google Scholar Wilder PJ, Kelly D, Brigman K, Peterson CL, Nowling T, Gao Q-S, McComb RD, Capecchi MR, Rizzino A. 1997. Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their differentiated progeny. Dev Biol 192: 614–629. Medline 10.1006/dbio.1997.8777 CASPubMedWeb of Science®Google Scholar Xu X, Weinstein M, Li C, Naski M, Cohen R, Ornitz D, Leder P, Deng C. 1998. Fibroblast growth factor receptor 2 (FGFR2)–mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753–765. Medline CASPubMedWeb of Science®Google Scholar Zmuidzinas A, Fischer K-D, Lira SA, Forrester L, Bryant S, Bernstein A, Barbacid M. 1995. The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro. EMBO J 14: 1–11. Medline 10.1002/j.1460-2075.1995.tb06969.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume52, Issue2February 1999Pages 234-240 ReferencesRelatedInformation

FGF receptor (FGFR) function is essential during peri-implantation mouse development. To understand which receptors are functioning, we tested for the expression of all four FGF receptors in peri-implantation blastocysts. By RT-PCR, FGFR-3 and FGFR-4 were detected at high levels, FGFR-2 at lower levels, and FGFR-1 was detected at background levels compared to control tissues. Because FGFR-3 and FGFR-4 were detected at the highest levels, we studied these in detail. Between 3.5 days after fertilization (E3.5) and E6.0, FGFR-4 mRNA was detected ubiquitously in the peri-implantation embryo, restricted to the inner cell mass (ICM) and its derivatives and primitive endoderm by E6.0, and was not detected at E6.5. FGFR-3 mRNA was detected ubiquitously in the peri-implantation embryo with a tendency towards extraembryonic cells. We tested blastocyst outgrowths, a model for implantation, for FGFR-3 and FGFR-4 protein. FGFR-3 protein was detected in all cells early during the outgrowth. Later, FGFR-3 was detected in the extraembryonic endoderm and trophoblast giant cells (TGC), but not in the ICM. FGFR-4 protein was detected in all cells of the implanting embryo, but was restricted to the ICM/primitive endoderm in later stage outgrowths. The distribution of the receptor proteins in the blastocyst outgrowths is similar to the distribution of the mRNA detected by in situ hybridization of sections of embryos. The data suggest roles for FGFR-3 and FGFR-4 in peri-implantation development. Mol. Reprod. Dev. 51:254–264, 1998. © 1998 Wiley-Liss, Inc.

Insulin and insulinlike growth factors are important for embryonic growth and metabolism. Intracellular transduction for these factors has not been studied in the preimplantation mouse embryo. Peri-implantation mouse embryos synthesize insulinlike growth factor (IGF)-II ligand, insulin receptor, IGF-I receptor, and IGF-II receptor and respond to IGF-II, IGF-I, and insulin metabolically and mitogenically. Maternal tissues in the oviduct and uterus are also sources of IGF-I and insulin. Signaling of IGFs occurs through insulin receptor substrate (IRS)-1 and IRS-2. This paper shows that IRS-1 mRNA and protein are highly expressed in preimplantation mouse embryos, in embryonic cell lines, and in cultured blastocyst outgrowths. IRS-1 mRNA and protein are detected in embryo-derived cell lines cultured to produce the three cell lineages (stem cells, endoderm, and trophoblast cells). IRS-1 mRNA is detected by reverse transcription-polymerase chain reaction (RT-PCR) in the E3.5 blastocyst before implantation and in F9 teratocarcinoma stem cells and parietal endoderm cells. IRS-1 mRNA is detected by Northern blot hybridization at high levels in stem cells and in differentiated progeny of F9 cells and C3H/NE trophectoderm cells. IRS-1 protein was detected in these cell lines and in an overexpressing CHO-IRS-1 fibroblast cell line by immunocytochemistry. Cultured blastocyst outgrowths are a model for implantation events of the trophoblast/placenta lineage and endoderm/yolk sac lineage. In the blastocyst outgrowth, IRS-1 protein is detected in inner cell mass cells (ICM cells), primitive endoderm, parietal endoderm, and trophectoderm cells. These data suggest that IRS-1 is expressed in all cell lineages of the peri-implantation mouse embryo and mediates some effects of insulin and IGFs at this stage. Mol. Reprod. Dev. 49:386–393, 1998. © 1998 Wiley-Liss, Inc.

Fibroblast growth factor (FGF) signaling is required prior to gastrulation in the mouse embryo. To test for the spatial and temporal requirements of FGF signaling, a dominant negative FGF receptor (dnFGFR) was used to make transgenic mouse embryos. In mosaic embryos, cell division ceased at the fifth cell division in all cells that expressed the mutant receptor, but cell death did not increase. After the fifth cell division, the progeny of unaltered cells and cells expressing lacZ continued to accumulate at the same rate, suggesting that the FGF requirement is cell autonomous. In mosaic embryos, lacZ, but not dnFGFR expression was detected in mitotic trophoblasts adjacent to the ICM. Conversely, dnFGFR-expressing extraembryonic ectoderm cells were detected at the abembryonic pole in postmitotic cells. In blastocysts expressing the dnFGFR in all cells, the morphology appeared normal and inner cell masses (ICMs) formed, but resultant embryos had only one-third the number of cells as control embryos. In these blastocysts, cell division had also ceased at the fifth cell division, but cavitation, a concurrent morphogenetic event, initiated and progressed normally. To test for the continuing requirement of FGF, FGFR-3 was overexpressed in all cells and resulted in an increase in cell numbers after the fifth cell cycle. In a model for postimplantation development, addition of FGF-4 to blastocyst outgrowths increased the number of extraembryonic ectoderm cells, suggesting a continuing role for FGF. Thus, FGF signaling induces the cell division of embryonic and extraembryonic cells in the preimplantation mouse embryo starting at the fifth cell division. The signal requirement for FGF is cell autonomous, but is not required to prevent cell death. This provides the first evidence for the necessity of a growth factor before implantation.

The intraovarian mechanisms for follicle recruitment, growth, maturation, and ovulation are not well understood. The data suggest that fibroblast growth factor (FGF)-2 is expressed in granulosa and theca cells of growing and mature follicles and in luteal cells during pregnancy. Exogenous FGF-2 modulates steroidogenesis, stimulates tissue plasminogen activator (tPA), and induces germinal vesicle breakdown (GVBD) in cultured follicles. Previously, we have reported that another FGF ligand, FGF-4, is expressed in ovulated mouse oocytes. Two studies have examined the expression of receptors (FGFR) for FGF ligands in the ovary. These prior reports have been limited to FGFR-1, one of the four isoforms that are variably expressed in adult mammalian tissues. This study evaluates FGFR-4 and FGFR-3 mRNA expression in the ovary. Granulosa cells from several follicular stages express the receptor for FGFR-4 mRNA as assayed by in situ hybridization. FGFR-4 mRNA is not expressed in theca cells or the oocyte. FGFR-3 mRNA is not detected in the ovary by in situ hybridization. These results suggest that FGFR-4 may play a role in mediating the effects of FGF ligands in follicular development in the ovary.

In the mouse, the heart primordium arises when mesoderm is set aside during gastrulation, is induced by pharyngeal endoderm, migrates ventrally to the midline of the embryo, forms a tube, and begins beating. Little is known of the molecular mechanisms that mediate the determination, mitosis, differentiation, and migration that lead to the beating heart. Transcripts for hepatocyte growth factor/scatter factor (HGF) and its receptor are coexpressed transiently and dynamically in the premyocardium but not in other heart progenitor cells. Transcripts the HGF ligand and receptor are first detected before cardiac function and looping and persist through the first looping stage, when heart morphology begins to elaborate. HGF ligand and receptor mRNA are detectable after the putative heart transcription factor, Csx/Nkx2-5, and concomitantly with the heart structural gene, cardiac actin. HGF receptor mRNA is detected in the mesoderm of the headfold stage and persists in myocardial precursors of the ventricles and atria (but not in the outflow-tract smooth muscle cells) through the 14-somite stage at approximately 8.75 days after fertilization (day E8.75). At the headfold stage, between E7.5 and E8.0, HGF receptor mRNA was detected in myocardial cells before fusion at the ventral midline. HGF ligand and receptor mRNA transcripts are coexpressed in the embryo, except in the headfold state (when only the HGF receptor can be detected) and in the heart at the 14- to 18-somite stage (when only HGF ligand can be detected). The dynamic pattern of coexpression suggests an autoregulatory role for HGF and its receptor in early heart development.

Injury to a peripheral nerve is followed by a remodeling process consisting of axonal degeneration and regeneration. It is not known how Schwann cell–derived basement membrane is preserved after injury or what role matrix metalloproteinases (MMPs) and their inhibitors play in axonal degeneration and regeneration. We showed that the MMPs gelatinase B (MMP-9), stromelysin-1 (MMP-3), and the tissue inhibitor of MMPs (TIMP)-1 were induced in crush and distal segments of mouse sciatic nerve after injury. TIMP-1 inhibitor activity was present in excess of proteinase activity in extracts of injured nerve. TIMP-1 protected basement membrane type IV collagen from degradation by exogenous gelatinase B in cryostat sections of nerve in vitro. In vivo, during the early phase (1 d after crush) and later phase (4 d after crush) after injury, induction of TNF-α and TGF-β1 mRNAs, known modulators of TIMP-1 expression, were paralleled by an upregulation of TIMP-1 and gelatinase B mRNAs. At 4 days after injury, TIMP-1, gelatinase B, and TNF-α mRNAs were localized to infiltrating macrophages and Schwann cells in the regions of nerve infiltrated by elicited macrophages. TIMP-1 and cytokine mRNA expression was upregulated in undamaged nerve explants incubated with medium conditioned by macrophages or containing the cytokines TGF-β1, TNF-α, and IL-1α. These results show that TIMP-1 may protect basement membrane from uncontrolled degradation after injury and that cytokines produced by macrophages may participate in the regulation of TIMP-1 levels during nerve repair.

We have examined the expression of SRY mRNA in individual in vitro fertilized preimplantation human embryos; because of ethical constraints, these studies were confined to embryos with one and three pronuclei. Using a sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) assay, we observed SRY mRNA at the one-cell through the blastula stages but not in spermatozoa. These results indicate that the de novo transcription of this sex-specific gene occurs at a developmental time considerably earlier than that of gonadal differentiation. Our results also indicate that in vitro fertilized embryos with one pronucleus are likely to be diploid.